N-[2-tert-butoxycarbamoyl-2-(4-methanesulphonylpiperazin-1-yl)ethyl]-4-but-2-ynyloxybenzamide → 4-but-2-ynyloxy-N-[2-hydroxycarbamoyl-2-(4-methanesulphonylpiperazin-1-yl)ethyl]benzamide
反応式
C([O:5][NH:6][C:7]([CH:9]([N:25]1[CH2:30][CH2:29][N:28]([S:31]([CH3:34])(=[O:33])=[O:32])[CH2:27][CH2:26]1)[CH2:10][NH:11][C:12](=[O:24])[C:13]1[CH:18]=[CH:17][C:16]([O:19][CH2:20][C:21]#[C:22][CH3:23])=[CH:15][CH:14]=1)=[O:8])(C)(C)C>FC(F)(F)C(O)=O>[CH2:20]([O:19][C:16]1[CH:15]=[CH:14][C:13]([C:12]([NH:11][CH2:10][CH:9]([C:7](=[O:8])[NH:6][OH:5])[N:25]2[CH2:30][CH2:29][N:28]([S:31]([CH3:34])(=[O:32])=[O:33])[CH2:27][CH2:26]2)=[O:24])=[CH:18][CH:17]=1)[C:21]#[C:22][CH3:23]参加物
3
実験手順
100 mg (0.2 mmol) of N-[2-tert-butoxycarbamoyl-2-(4-methanesulphonylpiperazin-1-yl)ethyl]-4-but-2-ynyloxybenzamide are placed in 3 ml of trifluoroacetic acid. After stirring for 8 days at ambient temperature, the mixture is concentrated under vacuum then the crude product is purified by chromatography over silica gel eluted with a 9/1 dichloromethane/methanol mixture. 30 mg (34%) of 4-but-2-ynyloxy-N-[2-hydroxycarbamoyl-2-(4-methanesulphonylpiperazin-1-yl)ethyl]benzamide are obtained in the form of a beige solid.
後処理
- concentrationthe mixture is concentrated under vacuum
- customthe crude product is purified by chromatography over silica gel
- washeluted with a 9/1 dichloromethane/methanol mixture
出典と根拠
- ORDレコード
- ord-cf84b45b95e44c9e9ab7a924a855630f
- 出典データセット
- uspto-grants-2015_08
- 特許番号
- US09115102B2
反応ノート
読み込み中…